We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+13.01%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$234B
AUM Growth
+$27.2B
Cap. Flow
+$4.48B
Cap. Flow %
1.91%
Top 10 Hldgs %
17.69%
Holding
6,610
New
800
Increased
2,296
Reduced
2,513
Closed
633

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$1.19B
2
PLTR icon
Palantir
PLTR
+$742M
3
HES
Hess
HES
+$478M
4
ORCL icon
Oracle
ORCL
+$465M
5
TRI icon
Thomson Reuters
TRI
+$442M

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Financials 7.68%
3 Healthcare 6.5%
4 Industrials 5.87%
5 Consumer Discretionary 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMCR icon
6101
CALL
Immunocore
IMCR
$1.9B
-15,000
Closed -$471K
IMVT icon
6102
CALL
Immunovant
IMVT
$9.16B
-50,000
Closed -$800K
INDV icon
6103
CALL
Indivior Pharmaceuticals
INDV
$4.35B
-107,200
Closed -$1.58M
INMB icon
6104
INmune Bio
INMB
$64.4M
-42,612
Closed -$98.4K
INMB icon
6105
PUT
INmune Bio
INMB
$64.4M
-50,000
Closed -$116K
INOD icon
6106
Innodata
INOD
$2.21B
-12,466
Closed -$630K
INSE icon
6107
Inspired Entertainment
INSE
$160M
-24,265
Closed -$198K
INSG icon
6108
Inseego
INSG
$72.1M
-14,447
Closed -$119K
INSM icon
6109
CALL
Insmed
INSM
$27.5B
-8,000
Closed -$805K
INSP icon
6110
CALL
Inspire Medical Systems
INSP
$1.8B
-15,200
Closed -$1.97M
INSP icon
6111
PUT
Inspire Medical Systems
INSP
$1.8B
-12,200
Closed -$1.58M
INZY
6112
DELISTED
Inozyme Pharma
INZY
-481,799
Closed -$1.93M
IONQ icon
6113
CALL
IonQ
IONQ
$18.2B
-8,100
Closed -$348K
IONQ icon
6114
PUT
IonQ
IONQ
$18.2B
-14,500
Closed -$623K
IPHA
6115
Innate Pharma
IPHA
$252M
-11,661
Closed -$20.4K
IQ icon
6116
iQIYI
IQ
$1.01B
-462,791
Closed -$819K
IRON icon
6117
CALL
Disc Medicine
IRON
$3.06B
-15,000
Closed -$794K
ISTR icon
6118
Investar Holding Corp
ISTR
$418M
-29,889
Closed -$577K
ITA icon
6119
iShares US Aerospace & Defense ETF
ITA
$14.2B
-3,655
Closed -$689K
ITB icon
6120
PUT
iShares US Home Construction ETF
ITB
$2.27B
-134,200
Closed -$12.5M
ITOS
6121
CALL
DELISTED
iTeos Therapeutics
ITOS
-342,500
Closed -$3.41M
ITOS
6122
DELISTED
iTeos Therapeutics
ITOS
-477,189
Closed -$4.76M
ITRI icon
6123
CALL
Itron
ITRI
$4.38B
-7,600
Closed -$1M
IWB icon
6124
iShares Russell 1000 ETF
IWB
$49.3B
-6,955
Closed -$2.36M
IWN icon
6125
iShares Russell 2000 Value ETF
IWN
$14.6B
-4,843
Closed -$764K

Similar funds

Israel Englander's Q3 2025 Portfolio in Review

As of Q3 2025, Israel Englander held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Israel Englander's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 8.7% a quarter earlier, followed by Financials and Healthcare.

  • Israel Englander's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
  • Israel Englander added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
  • Israel Englander's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
  • Israel Englander fully exited Hess in Q3 2025, selling an estimated $478M.
  • Israel Englander's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
  • Israel Englander opened 800 new positions and closed 633 in Q3 2025.
  • Israel Englander's portfolio value rose 13% quarter-over-quarter to $234B.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.